title: Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes.
authors.affiliation: Diabetes Division, University of Texas Health Science Center, San Antonio, Texas, USA. albarado@uthscsa.edu
authors.forename: Ralph A
authors.initials: RA
authors.lastname: DeFronzo
authors.forename: Roy
authors.initials: R
authors.lastname: Eldor
authors.forename: Muhammad
authors.initials: M
authors.lastname: Abdul-Ghani
mesh_terms: D000465:Algorithms; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D004359:Drug Therapy, Combination / Q000379:methods; D052216:Glucagon-Like Peptide 1 / Q000008:administration & dosage; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000008:administration & dosage; D007333:Insulin Resistance / Q000502:physiology; D050417:Insulin-Secreting Cells / Q000502:physiology; D008099:Liver / Q000502:physiology; D008687:Metformin / Q000008:administration & dosage; D009132:Muscles / Q000502:physiology
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin; D052216:Glucagon-Like Peptide 1; D008687:Metformin